GAITHERSBURG, Md.–Ocimum Biosolutions is proud to announce its partnership with Clarmon Corporation to distribute, implement and support its Compliance Management Solution, QAvalid™. Ocimum Biosolutions’ extensive knowledge of Computer Systems Validation requirements and processes as well as its extensive understanding of pharmaceutical and biotechnology laboratories combined with Clarmon’s unique solution, QAvalid™, creates a valuable partnership for […]

Companies to Cooperate on Development of Dose Optimization Capability for Early Discovery LANCASTER, Calif.–Simulations Plus, Inc. (Nasdaq:SLP), the leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has signed a collaboration agreement with a top-three pharmaceutical company to extend and enhance its ADMET Predictor™ program to predict the […]

InforSense Expands Into Operational Healthcare Analytics Market LONDON and CAMBRIDGE, MA, Nov 24, 2008 — InforSense Ltd., the leading provider of next generation business and scientific intelligence solutions, today announced it has signed a deal with NorDx, one of the leading independent clinical labs in the US northeast and a member of the MaineHealth system. […]

TUCSON, Ariz.–HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, today announced it has appointed Fredrick L. Pollock to Vice President of Corporate Development. Pollock will be responsible for leading commercial sales efforts in the academic and research markets, spearheading efforts for bio-marker and signature […]

New hire brings over 20 years of commercial life sciences sales experience to Cyntellect SAN DIEGO, Nov. 21 — Cyntellect, a privately-held life sciences company leading the development and commercialization of live cell analysis and manipulation systems, announced today that it has appointed Andre Lubarsky as the Company’s Director of Sales – North America. Andre […]

ST. LOUIS, Nov. 20 — Sigma-Aldrich (Nasdaq: SIAL) announced today the global release of MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA. MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA are expected to allow researchers to successfully take the next step in their RNAi research with the highest purity and quality siRNA required for RNAi […]

GE Global Research, the technology development arm for the General Electric Company (NYSE:GE), announced today a two-year, $1.1 million collaboration with the Transformational Medical Technologies Initiative (TMTI) to develop a physiologically based “virtual human.” This collaboration is supported by a contract awarded by the Defense Threat Reduction Agency (DTRA), a division of the U.S. Department […]

SAN DIEGO, Nov. 20 — Cyntellect, a privately-held life sciences company leading the development and commercialization of live cell analysis, manipulation and purification systems, announced today that it has entered a research collaboration agreement with the University of Florida Interdisciplinary Center for Biotechnology Research. The agreement will focus on a variety of research areas including […]

Acquisition Extends Data Analysis and Visualization Capabilities SEATTLE–Geospiza, Inc. and VizX Labs today announced a definitive agreement whereby Geospiza, a privately held developer of genetic analysis software, has acquired the award-winning GeneSifter Data Analysis product. This product will provide scientists a true sample to results solution for gene expression for both microarrays and next generation […]

The study of microbial communities from environmental samples, known as metagenomics, has been propelled forward by technological advancements in high-throughput, low-cost sequencing such as 454’s Genome Sequencer FLX System. With the recent use of sequencing approaches for metagenomic analysis, the major research challenges have shifted from generating to analyzing data. To resolve these analysis bottlenecks, […]